Literature DB >> 30342083

Hidden antibiotics: Where to uncover?

Maarten L De Mol1, Nico Snoeck1, Sofie L De Maeseneire2, Wim K Soetaert1.   

Abstract

The struggle of humans versus pathogens is a never ending battle. Since the discovery of antibiotics humans have tipped the scales in their favour, but today bacteria are nullifying this advantage by developing resistance mechanisms against these molecules. The plethora of different antibiotics active against pathogens is shrinking while the discovery of new molecules is arduous. Especially the development of drugs active against Gram- pathogens continues slowly. New strategies to discover novel, potent antibiotics are hence needed. Adopting the optimistic view of technological singularity, innovative and disruptive approaches are required and hence proposed to lift the current conundrum. In this review, questions are answered on where and how to look for new natural product hit molecules with antibacterial activity, on how the field of synthetic biology can aid the contemporary pharmaceutical challenge and whether we are ready to make the transition towards other approaches, such as narrow-spectrum antibiotics and phage therapy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug hit; Genome Mining; Habitat Profiling; Hidden Antibiotics; LoDDaD; Nagoya; Natural Product; Synthetic Biology

Mesh:

Substances:

Year:  2018        PMID: 30342083     DOI: 10.1016/j.biotechadv.2018.10.008

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  2 in total

1.  Antibacterial Discovery: 21st Century Challenges.

Authors:  Paul S Hoffman
Journal:  Antibiotics (Basel)       Date:  2020-04-28

Review 2.  Technologies for High-Throughput Identification of Antibiotic Mechanism of Action.

Authors:  Bernardo Ribeiro da Cunha; Paulo Zoio; Luís P Fonseca; Cecília R C Calado
Journal:  Antibiotics (Basel)       Date:  2021-05-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.